discontinued

AP55561CP-N ECRG-2 (C-term) Control Peptide

Search for all "ECRG-2"

Quick Overview

anti ECRG-2

Product Description for ECRG-2

anti ECRG-2.
Properties: (C-term) Control Peptide

Properties for ECRG-2

Product Category Control Peptides
Target Category
Quantity 50 µg
Synonyms ECG2, Esophagus cancer-related gene 2 protein, MGC133105, MGC133106, SPINK7, Serine protease inhibitor Kazal-type 7, UNQ745/PRO1474
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer OriGene Technologies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datasheet Extract

Immunogen
Swiss Prot Num:
P58062
GeneID:
84651
Property C-term
Application

The peptide is used for blocking the activity of ECRG-2antibody Cat.-No. AP55561PU-N. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37°C.

Concentration 0.2 mg/ml
General Readings Cui Y, Wang J, Zhang X, et al. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem. Biophys. Res. Commun. 2003; 302:904-15.
Storage

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Format
Buffer System:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% BSA and 0.02% Sodium azide
State:
Liquid peptide
Specificity
Specificity:
Control peptide for AP55561PU-N.Peptide containing 16 amino acids near the carboxy terminus of human ECRG2.
Species:
Human

Accessory Products

  • LinkedIn